Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer.
Zhang J, Zhang G, Zhang W, Bai L, Wang L, Li T, Yan L, Xu Y, Chen D, Gao W, Gao C, Chen C, Ren M, Jiao Y, Qin H, Sun Y, Zhi L, Qi Y, Zhao J, Liu Q, Liu H, Wang Y.
Zhang J, et al. Among authors: gao c, gao w.
Cell Death Differ. 2022 Nov;29(11):2247-2261. doi: 10.1038/s41418-022-01012-0. Epub 2022 May 10.
Cell Death Differ. 2022.
PMID: 35538152
Free PMC article.